Erbb3 Signaling (Clinical Trials) Equipment
1 equipment items found
-
Manufactured by AVEO Pharmaceuticals, Inc.based in USA
AV-203 (CAN017) is a clinical-stage ErbB3 (HER3) inhibitory antibody candidate designed to inhibit both ligand-dependent and ligand-independent ErbB3 signaling. ErbB3 is a receptor that is typically expressed in many human cancers, and AV-203 has demonstrated preclinical activity in a number of different tumor models including ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you